| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K03536150 |
| PharmacoGx | BRD-K03536150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HCRT | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | PPP3CC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | C19orf45 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ZNF486 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SIRPB1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | XRCC3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PLA2G4C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NKX2-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CFD | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AD000671.6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
